Suppliers / Exela Pharma Sciences

Exela Pharma Sciences

United States 343 employees Updated 9 July 2026

Exela Pharma Sciences is a finished-dose manufacturer based in United States. It appears in 22 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
22
filings across 1 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 22 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Comparing suppliers?

Choose your molecules and target markets. Exela Pharma Sciences comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • One recent serious compliance event is on record.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability